0000902664-21-001476.txt : 20210217
0000902664-21-001476.hdr.sgml : 20210217
20210217214028
ACCESSION NUMBER: 0000902664-21-001476
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210215
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOEL DAVID E.
CENTRAL INDEX KEY: 0001548144
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38957
FILM NUMBER: 21647497
MAIL ADDRESS:
STREET 1: C/O MATRIX CAPITAL MANAGEMENT CO., LP
STREET 2: 1000 WINTER STREET, SUITE 4500
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp
CENTRAL INDEX KEY: 0001478320
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270907024
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-659-0067
MAIL ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptive TCR Corp
DATE OF NAME CHANGE: 20091209
4
1
ownership.xml
X0306
4
2021-02-15
0
0001478320
Adaptive Biotechnologies Corp
ADPT
0001548144
GOEL DAVID E.
C/O MATRIX CAPITAL MANAGEMENT CO., LP
1000 WINTER STREET, SUITE 4500
WALTHAM
MA
02451
1
0
0
0
Common Stock
2021-02-15
4
A
0
1504
0
A
1504
D
Stock Option (Right to Buy)
66.5
2021-02-15
4
A
0
3759
0
A
2031-02-15
Common Stock
3759
3759
D
The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date.
/s/ David E. Goel
2021-02-17